Patents by Inventor Eddie Sullivan

Eddie Sullivan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and Methods for the Production of Human Polyclonal Antibodies
    Publication number: 20220153817
    Abstract: Disclosed herein is a method for producing human antibodies against a pathogen comprising injecting a non-human animal with a pathogen-derived DNA vaccine in at least two locations of the animal; injecting the animal with an adjuvant in a location of the animal different from the location of the DNA vaccine location; collecting plasma from the animal after the injections; and purifying polyclonal antibody from the plasma.
    Type: Application
    Filed: June 30, 2021
    Publication date: May 19, 2022
    Inventors: Jay HOOPER, Eddie SULLIVAN, Hua WU
  • Systems and methods for the production of human polyclonal antibodies
    Patent number: 11072649
    Abstract: Disclosed herein is a method for producing human antibodies against a pathogen comprising injecting a non-human animal with a pathogen-derived DNA vaccine in at least two locations of the animal; injecting the animal with an adjuvant in a location of the animal different from the location of the DNA vaccine location; collecting plasma from the animal after the injections; and purifying polyclonal antibody from the plasma.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: July 27, 2021
    Assignee: SAB, LLC
    Inventors: Jay Hooper, Eddie Sullivan, Hua Wu
  • Systems and Methods for the Production of Human Polyclonal Antibodies
    Publication number: 20170233459
    Abstract: Disclosed herein is a method for producing human antibodies against a pathogen comprising injecting a non-human animal with a pathogen-derived DNA vaccine in at least two locations of the animal; injecting the animal with an adjuvant in a location of the animal different from the location of the DNA vaccine location; collecting plasma from the animal after the injections; and purifying polyclonal antibody from the plasma.
    Type: Application
    Filed: November 25, 2016
    Publication date: August 17, 2017
    Inventors: Jay Hooper, W, Eddie Sullivan, Hua Wu
  • Transgenic ungulates capable of human antibody production
    Patent number: 7803981
    Abstract: The invention features novel methods for the production of large quantities of xenogenous antibodies, such as human antibodies. Preferably, this result is effected by inactivation of IgM heavy chain expression and, optionally, by inactivation of Ig light chain expression, and by the further introduction of an artificial chromosome which results in the expression of xenogenous antibodies (e.g., non-bovine antibodies), preferably human antibodies.
    Type: Grant
    Filed: June 20, 2007
    Date of Patent: September 28, 2010
    Assignee: Kyowa Hakko Kirin Co., Ltd.
    Inventors: James M. Robl, Philippe Collas, Eddie Sullivan, Poothappillai Kasinathan, Richard A. Goldsby, Yoshimi Kuroiwa, Kazuma Tomizuka, Isao Ishida, Barbara Osborne
  • Transgenic ungulates capable of human antibody production
    Publication number: 20080040821
    Abstract: The invention features novel methods for the production of large quantities of xenogenous antibodies, such as human antibodies. Preferably, this result is effected by inactivation of IgM heavy chain expression and, optionally, by inactivation of Ig light chain expression, and by the further introduction of an artificial chromosome which results in the expression of xenogenous antibodies (e.g., non-bovine antibodies), preferably human antibodies.
    Type: Application
    Filed: June 20, 2007
    Publication date: February 14, 2008
    Inventors: James Robl, Philippe Collas, Eddie Sullivan, Poothappillai Kasinathan, Richard Goldsby, Yoshimi Kuroiwa, Kazuma Tomizuka, Isao Ishida, Barbara Osborne
  • Methods for cloning non-human mammals using reprogrammed donor chromatin or donor cells
    Patent number: 7253334
    Abstract: The invention provides methods for cloning mammals that allow the donor chromosomes or donor cells to be reprogrammed prior to insertion into an enucleated oocyte. The invention also features methods of inserting chromosomes or nuclei into recipient cells.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: August 7, 2007
    Assignee: Aurox, LLC
    Inventors: Philippe Collas, James M. Robl, Eddie Sullivan, Poothappillai Kasinathan
  • Methods for cloning mammals using reprogrammed donor chromatin or donor cells
    Publication number: 20060212952
    Abstract: The invention provides methods for cloning mammals that allow the donor chromosomes or donor cells to be reprogrammed prior to insertion into an enucleated oocyte. The invention also features methods of inserting chromosomes or nuclei into recipient cells.
    Type: Application
    Filed: May 24, 2006
    Publication date: September 21, 2006
    Inventors: Philippe Collas, James Robl, Eddie Sullivan, P. Kasinathan
  • Transgenic ungulates capable of human antibody production
    Publication number: 20040068760
    Abstract: The invention features novel methods for the production of large quantities of xenogenous antibodies, such as human antibodies. Preferably, this result is effected by inactivation of IgM heavy chain expression and, optionally, by inactivation of Ig light chain expression, and by the further introduction of an artificial chromosome which results in the expression of xenogenous antibodies (e.g., non-bovine antibodies), preferably human antibodies.
    Type: Application
    Filed: May 19, 2003
    Publication date: April 8, 2004
    Inventors: James M. Robl, Philippe Collas, Eddie Sullivan, P. Kasinathan, Richard A. Goldsby, Yoshimi Kuroiwa, Kazuma Tomizuka, Isao Ishida
  • Methods for cloning mammals using reprogrammed donor chromatin or donor cells
    Publication number: 20030046722
    Abstract: The invention provides methods for cloning mammals that allow the donor chromosomes or donor cells to be reprogrammed prior to insertion into an enucleated oocyte. The invention also features methods of inserting chromosomes or nuclei into recipient cells.
    Type: Application
    Filed: December 21, 2001
    Publication date: March 6, 2003
    Inventors: Philippe Collas, James M. Robl, Eddie Sullivan, P. Kasinathan